Activity Overview
This educational activity is an archive of the live conference held on March 13-14, 2026.
Target Audience
This educational activity is directed toward medical, surgical,
and radiation oncologists involved in the treatment of patients with GU
malignancies. Urologists, fellows, nurse practitioners, nurses, physician
assistants, pharmacists, researchers, nuclear medicine physicians, and other
health care professionals interested in the treatment of GU malignancies may
also participate.
Learning Objectives
- Interpret advanced diagnostic and molecular testing strategies—including ctDNA and genomic profiling—for risk stratification and disease monitoring in GU malignancies
- Integrate emerging therapies with multidisciplinary strategies to optimize treatment sequencing and coordination across specialties
- Apply molecular and genomic test results to guide treatment selection and personalize care in patients with GU cancers
- Integrate emerging therapies with multidisciplinary strategies to optimize treatment sequencing and coordination across specialties
Daniel P. Petrylak, MD
Professor of Medicine (Medical Oncology) and Urology
Director, Genitourinary Oncology Research Program
Co-Director, Signal Transduction Program
Yale Cancer Center
Yale School of Medicine
New Haven, CT
E. David Crawford, MD
Professor of Urology
Jack A. Vickers Director of Prostate Research
University of California, San Diego
Koman Family Outpatient Pavilion
La Jolla, CA
David H. Aggen, MD, PhD
Assistant Attending Physician
Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY
Fed Ghali, MD
Assistant Professor of Urology
Division of Urologic Oncology
Yale School of Medicine
New Haven, CT
Saum B. Ghodoussipour, MD
Assistant Professor, Section of Urologic Oncology
Rutgers Robert Wood Johnson (RWJ) Medical School
Urologic Oncologist
Robert Wood Johnson University Hospital
Director, Bladder and Urothelial Cancer Program
Rutgers Cancer Institute of New Jersey
New Brunswick, NJ
Himanshu Nagar, MD, MS
Director of Genitourinary Cancers
Department of Radiation Oncology
Memorial Sloan Kettering Cancer Center
New York, NY
Cora N. Sternberg, MD, FACP
Clinical Director, Englander Institute for Precision Medicine
Professor of Medicine
Sandra and Edward Meyer Cancer Center
Weill Cornell Medicine
New York-Presbyterian
New York, NY
David B. Solit, MD
Geoffrey Beene Chair in Cancer Research
Co-Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Chief, Molecular Medicine Service, Human Oncology and Pathogenesis Program
Memorial Sloan Kettering Cancer Center
New York, NY
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.